1例先天性心脏病合并感染性心内膜炎患儿的用药分析和药学监护
x

请在关注微信后,向客服人员索取文件

篇名: 1例先天性心脏病合并感染性心内膜炎患儿的用药分析和药学监护
TITLE:
摘要: 目的:为感染性心内膜炎患儿的个体化合理治疗提供参考。方法:针对我院2017年4月收治的1例先天性心脏病合并感染性心内膜炎患儿,临床药师全程提供药学监护,依据患儿个体情况,当治疗效果不佳时,及时查阅指南、文献并结合自身工作经验提出用药建议。结果:患儿使用万古霉素常规剂量38 mg/(kg·d)治疗后,万古霉素血药谷浓度低(1.3 μg/mL),治疗效果不佳。临床药师两次提出建议调整万古霉素剂量,第一次调整剂量为45 mg/(kg·d),第二次调整剂量为60 mg/(kg·d),医师均采纳。调整治疗后,患儿体温正常,万古霉素血药谷浓度提高到5.8~6.5 μg/mL,病情得到控制。结论:在万古霉素治疗的儿童感染性心内膜炎治疗过程中,临床药师应全程提供药学监护,密切关注万古霉素的的血药谷浓度,以保障患儿合理用药。
ABSTRACT: OBJECTIVE: To provide reference for optimizing the treatment of children with infective endocarditis. METHODS: Clinical pharmacists provide whole process pharmaceutical care for a child with congenital heart disease and infective endocarditis admitted to our hospital in April 2017.  According to the individual situation of child, when therapy efficacy was poor, medication suggestions were put forward by timely referring to the guide and literature as well as combined with pharmacists’ work experience. RESULTS: After treatment with vancomycin at normal dose of 38 mg/(kg·d), the vancomycin blood concentration (1.3 μg/mL) was low, and the treatment effect was poor. Clinical pharmacist made two suggestions to adjust the dose of vancomycin. The first dose was 45 mg/(kg·d), the second dose was 60 mg/(kg·d); pediatrician adopt clinical pharmacist recommendations completely. After treatment, the child’s body temperature was normal; vancomycin blood trough concentration increased to 5.8-6.5 μg/mL, and the disease was controlled. CONCLUSIONS: During vancomycin treatment of infective endocarditis in children, clinical pharmacists should provide pharmaceutical care throughout the course and pay close attention to the blood trough concentration of vancomycin in order to ensure the rational use of drugs in children.
期刊: 2019年第30卷第7期
作者: 黄春,刘滔滔,蒋霞,唐双意,丘岳
AUTHORS: HUANG Chun,LIU Taotao,JIANG Xia,TANG Shuangyi,QIU Yue
关键字: 儿童;先天性心脏病;感染性心内膜炎;万古霉素;药学监护
KEYWORDS: Children; Congenital heart; Infective endocarditis; Vancomycin; Pharmaceutical care
阅读数: 413 次
本月下载数: 9 次

* 注:未经本站明确许可,任何网站不得非法盗链资源下载连接及抄袭本站原创内容资源!在此感谢您的支持与合作!